Rob Kalejta's lab is looking for a new colleague to continue our examination of herpesvirus-mediated oncogenic transformation. Our work in this area focuses on two viruses, human cytomegalovirus (HCMV) and Epstein-Barr Virus (EBV). For HCMV, projects include: 1) Understanding the role of the v-CDK UL97 during viral infection; 2) Defining how the retinoblastoma (Rb) tumor suppressor supports viral infection; 3) determining the viral proteins and mechanisms that convert glioblastoma (GBM) cells into cancer stem cells. For EBV, projects include: 1) Defining the roles of v-CDK BGLF4 (PK) substrates during viral infection; 2) Exploring the different epigenetic states of EBV genomes during latency.
We seek productive and motivated colleagues to join us in these challenges. Send Rob a CV and a one page description of research accomplishments and future goals. The Kalejta Lab accepts colleagues whose visions align with our commitment to diversity and inclusivity.